Today: 14 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Nebius (NBIS) stock slides 3% as tech weakens; investors eye next AI-cloud catalysts

Nebius (NBIS) stock slides 3% as tech weakens; investors eye next AI-cloud catalysts

Nebius Group N.V. shares fell 3.3% to $101.95 Wednesday afternoon, extending a volatile week for the AI infrastructure firm. Investors are watching a Jan. 29 product webinar and a February delivery milestone tied to a $2.9 billion Meta contract. The stock has swung sharply, jumping 9.6% Monday and falling 1.8% Tuesday. Tech stocks broadly declined, with Nvidia down 2.2% and the Nasdaq-100 ETF off 1.4%.
14 January 2026
···
Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

Lockheed Martin shares rose 2.3% to $571.40 Wednesday after the company announced its first flight test of the Next-Generation Short-Range Interceptor at White Sands. The gains outpaced the S&P 500, which fell 0.8%. Investors responded to new Pentagon efforts to secure the missile supply chain, including a $1 billion investment in L3Harris Technologies’ rocket-motor division.
14 January 2026
····
RTX stock rises as Airbus flags “very, very late” Pratt & Whitney engine deliveries

RTX stock rises as Airbus flags “very, very late” Pratt & Whitney engine deliveries

RTX shares rose 1.6% to $197.29 Wednesday, outperforming a weaker U.S. market after Airbus warned that Pratt & Whitney engine deliveries remain “very, very late.” Airbus said it has not reached a supply agreement with RTX for future engines. Investors are watching RTX’s Jan. 27 earnings for 2026 guidance and updates on engine production.
14 January 2026
······
Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer shares rose 2% to $25.65 Wednesday after CEO Albert Bourla said the company is “all in on obesity” and plans 10 Phase 3 trials for its Metsera compounds by 2026. Pfizer does not expect revenue growth to return until 2029 as it faces patent expirations and weaker COVID-related sales. AbbVie also announced new obesity drug plans. Novo Nordisk warned of tougher competition in 2026.
14 January 2026
···
SoFi stock drops 3% as “Trump Accounts” plan lands and investors eye Jan. 30 results

SoFi stock drops 3% as “Trump Accounts” plan lands and investors eye Jan. 30 results

SoFi Technologies shares fell 3.1% to $26.31 Wednesday after the company disclosed it sold nearly 58 million shares in a public offering, increasing dilution. The drop came as U.S. bank and tech stocks slid, with the S&P 500 down 0.8% and Nasdaq off 1.5%. SoFi also announced it will match the federal government’s $1,000 “Trump Account” seed for employees’ children. Quarterly results are due Jan. 30.
14 January 2026
·
Morgan Stanley stock slips as bank earnings spark a pullback ahead of Thursday results

Morgan Stanley stock slips as bank earnings spark a pullback ahead of Thursday results

Morgan Stanley shares fell 1.3% to $180.45 Wednesday, tracking a broader 2.5% drop in the S&P 500 bank index as financial stocks slid ahead of the bank’s quarterly results. The sector faced pressure from early earnings misses and uncertainty over President Trump’s proposed 10% cap on credit card interest rates. Wells Fargo led losses, down 5.6% after missing profit estimates.
14 January 2026
·
Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

Fiserv shares rose 0.1% to $66.81 Wednesday afternoon, bucking a broader market slide as the S&P 500 ETF fell 0.8%. Synchrony expanded CareCredit integration with Fiserv’s Clover platform, now reaching over 40,000 providers. Investors await Fiserv’s next earnings date, still unconfirmed. The stock remains volatile after October’s outlook cut and leadership changes.
14 January 2026
······
CrowdStrike stock slips after judge tosses outage lawsuit as CRWD pushes deeper into browser security

CrowdStrike stock slips after judge tosses outage lawsuit as CRWD pushes deeper into browser security

CrowdStrike shares fell 1.7% to $459.98 Wednesday after a U.S. judge dismissed a shareholder fraud lawsuit tied to the company’s July 2024 outage. The judge ruled investors failed to show CrowdStrike misled them about software testing. The New York State Common Retirement Fund said it is reviewing the decision. CrowdStrike also announced a deal to acquire Seraphic Security, with closing expected in its first fiscal quarter of 2027.
14 January 2026
··
Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom

Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom

Uber shares fell 1.3% after New York City accused the company and DoorDash of redesigning their apps to cut delivery workers’ tips by $554 million. The city’s new law requiring apps to offer a tipping option at checkout takes effect Jan. 26, with both firms challenging the rule in court. Uber will shift its key profit metric from adjusted EBITDA to non-GAAP operating income starting in 2026. DoorDash and Lyft shares also declined.
14 January 2026
··
Delta Air Lines stock slides again after 2026 outlook — here’s what investors watch next

Delta Air Lines stock slides again after 2026 outlook — here’s what investors watch next

Delta Air Lines shares fell about 2% to $67.97 after the company forecast 2026 adjusted earnings per share of $6.50 to $7.50 and free cash flow of $3 billion to $4 billion. Delta also committed to buy 30 Boeing 787-10 jets, with deliveries starting in 2031. Main-cabin ticket revenue dropped 7% last quarter, while premium revenue rose 9%. United, American, and Southwest shares also declined.
14 January 2026
··
PepsiCo stock climbs as investors crowd into defensive staples during Wall Street slide

PepsiCo stock climbs as investors crowd into defensive staples during Wall Street slide

PepsiCo shares rose 1.7% to $145.98 Wednesday, outperforming the S&P 500 ETF’s 0.8% drop as investors shifted to defensive stocks after mixed bank earnings. Evercore ISI reaffirmed its “In Line” rating and $152 target, citing upcoming management commentary. PepsiCo remains about 10% below its March 52-week high. The company will report Q4 and full-year results on Feb. 3.
14 January 2026
·
BMNR stock rises as BitMine pushes last-minute vote on plan to lift share cap to 50 billion

BMNR stock rises as BitMine pushes last-minute vote on plan to lift share cap to 50 billion

BitMine Immersion Technologies shares rose 4% to $32.46 after urging shareholders to approve a charter amendment raising authorized shares from 500 million to 50 billion. The company warned it may soon run out of shares to issue. A quarterly filing showed a $5.20 billion net loss, driven by a $5.25 billion unrealized loss on digital assets. Volume topped 51 million shares as ether and bitcoin prices climbed.
14 January 2026
·
1 … 310 311 312 313 314 … 704

Stock Market Today

  • Oil Crisis Sparks Economic Fears but Stock Market Remains Unshaken
    March 14, 2026, 10:16 AM EDT. Oil supply disruptions in the Middle East have ignited fears of rising inflation, higher interest rates, and potential stagflation-a combination of stagnant growth and inflation. Prices at the pump and grocery stores are climbing, pushing up costs for Canadian households. Despite the turmoil, U.S. and Canadian stock markets have only fallen 4% and 5% respectively since the crisis began, a calm seen by experts as misleading. The Strait of Hormuz's role as a critical global oil and gas transit point emphasizes the fragility of the world economy. Rising bond yields now affect mortgage rates, squeezing consumers further. Experts caution against taking full market risk amid the uncertain geopolitical financial landscape, warning of chaotic outcomes as the ripple effects expand.
Go toTop